Topical naphazoline in the treatment of myasthenic blepharoptosis

Muscle and Nerve

Volumn 44, Issue 1, 2011, Pages 41-44

  Nagane, Yuriko ^a   Utsugisawa, Kimiaki ^a   Suzuki, Shigeaki ^b   Masuda, Masayuki ^c   Shimizu, Yuko ^d   Utsumi, Hiroya ^c   Uchiyama, Shinichiro ^d   Suzuki, Norihiro ^b  

^a Hanamaki General Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Blepharoptosis; Eyewash; Myasthenia gravis; Naphazoline; Open trial

Indexed keywords

CALCINEURIN INHIBITOR; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; NAPHAZOLINE; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EYE EXAMINATION; EYE MOVEMENT; FEMALE; HUMAN; HUMAN TISSUE; ICE PACK TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYASTHENIA GRAVIS; MYASTHENIC BLEPHAROPTOSIS; OPEN STUDY; PATIENT SATISFACTION; PHOTOPHOBIA; PRIORITY JOURNAL; PTOSIS; PUPIL; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE; VISION; VISUAL FIELD;

ADMINISTRATION, TOPICAL; ADULT; AGED; BLEPHAROPTOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NAPHAZOLINE; PHARMACEUTICAL SOLUTIONS; TREATMENT OUTCOME;

EID: 79959285856     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22002     Document Type: Article

References (10)

1. Evoli A, Tonali P, Bartoccioni E, Lo Monaco M. Ocular myasthenia: diagnostic and therapeutic problems. Acta Neurol Scand 1988;77:31-35.
2. Benatar M, Kaminski HJ; Quality Standards Subcommittee of the American Academy of Neurology. Evidence report: The medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;68:2144-2149.
3. Bhanushali MJ, Wuu J, Benatar M. Treatment of ocular symptoms in myasthenia gravis. Neurology 2008;71:1335-1341.
4. Roach ES. Treating ocular myasthenia gravis with inadequate evidence. Arch Neurol 2007;64:1794-1795.
5. Tomelleri G, Vattemi G, Filosto M, Tonin P. Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: a simple test to identify this condition. J Neurol Neurosurg Psychiatry 2007;78:632-634.
6. Uncini A, De Nicola G, Di Muzio A, Rancitelli G, Colangelo L, Gambi D, et al. Topical naphazoline in treatment of myopathic ptosis. Acta Neurol Scand 1993;87:322-324.
7. Chatzistefanou KI, Kouris T, Iliakis E, Piaditis G, Tagaris G, Katsikeris N, et al. The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology 2009;116:2236-2243.
8. Jaretzki A III, Barohn RJ, Ernstoff RM, et al.; Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia gravis: recommendation for clinical research standards. Neurology 2000;55:16-23.
9. Provenzano C, Marino M, Scuderi F, Evoli A, Bartoccioni E. Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. J Neuroimmunol 2010;218:102-106.
10. Brimijoin S, Lennon VA. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc Natl Acad Sci USA 1990;87:9630-9634.